GHK-Cu in Bone, Cartilage and Tissue-Engineering Scaffolds: Stem Cells, Implant Coatings and Biomaterial Models

RESEARCH · GHK-CU · BONE, CARTILAGE AND SCAFFOLDS

GHK-Cu in Bone, Cartilage and Tissue-Engineering Scaffolds: Stem Cells, Implant Coatings and Biomaterial Models

PurixLab’s GHK-Cu 50mg is a research vial of the copper complex of the tripeptide glycyl-L-histidyl-L-lysine. Our earlier articles cover a research overview, gene expression and matrix remodelling, copper coordination chemistry, skin delivery and formulation and antioxidant and inflammation models. This article turns to a materials-science literature: GHK and GHK-Cu as bioactive components of scaffolds for bone, cartilage, soft-tissue and nerve repair, and their effects on stem and stromal cells. Almost all of this work is in cell culture or animal models, and in most of it the peptide is one part of an engineered construct. The material is supplied for laboratory research use only, and nothing here describes effects of any PurixLab product.

Why a matrix fragment interests materials scientists

GHK occurs within larger matrix proteins. Godet and Marie noted that the GHK sequence is present in the alpha 2 chain of type I collagen [1], and Jose and colleagues described GHK as a fragment of osteonectin (SPARC), a matricellular protein [2]. A short, stable sequence that can be grafted onto a polymer is attractive to scaffold designers who want to mimic matrix signals without full-length growth factors or proteins. GHK also binds copper(II), so the same peptide can act as a copper carrier [3,4].

Early work: osteoblasts, chondrocytes and collagen implants

In rat and human osteoblastic cells, GHK and GHK-Cu coatings increased cell attachment but did not affect spreading, and GHK-Cu coating slightly inhibited alkaline phosphatase activity and osteocalcin production [1]. That mixed result is a useful reminder that “more attachment” does not automatically mean “more bone formation”. In chick embryo chondrocytes grown on collagen supports, adding the copper-bound tripeptide to culture medium stimulated proliferation and collagen synthesis, and the authors suggested it might help in preparing cartilage implants [5].

Another group tested a collagen gel containing GHK, an antibiotic and a hypersulphated glycosaminoglycan in guinea-pig femoral bone defects. Unfilled defects healed slowest; defects filled with the gel without GHK healed faster, and the complete formulation was fastest [6]. Because GHK was one of several components, the experiment cannot isolate its contribution.

Stem and stromal cells in GHK-modified hydrogels

Two studies coupled GHK covalently to alginate. In human mesenchymal stem/stromal cells, GHK increased VEGF secretion in a concentration-dependent way, and cells entrapped in GHK-modified gels secreted more VEGF and basic FGF than in unmodified gels. Blocking alpha 6 and beta 1 integrins abolished the VEGF response, pointing to an integrin-mediated mechanism [2]. In umbilical cord blood mesenchymal stem cells encapsulated in oxidised alginate, GHK-functionalised gels improved osteogenic differentiation by gene expression, alkaline phosphatase activity and bone matrix deposition compared with gelatin-containing controls, and metabolomics profiles of the differentiated cells resembled primary osteoblasts [7]. Both abstracts describe the GHK peptide itself rather than the copper complex.

Newer bone constructs: microspheres, conjugates and coatings

Recent work grafts GHK-Cu onto engineered carriers. Porous, open-hollow nanofibrous microspheres made from poly(γ-benzyl-L-glutamate) with covalently grafted GHK-Cu raised bone marrow stem cell mineralisation and increased Runx2, OPN and OCN expression by 1.61-, 3.53- and 2.29-fold over unmodified microspheres, with angiogenic activity in tube-formation assays [8]. Hyaluronan-GHK conjugates bound copper(II) and increased the expression and release of BDNF, VEGF and BMP-2 in vitro, which the authors linked to nuclear translocation of the copper chaperones CCS and Atox1 [9].

For metal implants, chitosan coatings containing roughly 100 nm mesoporous silica nanoparticles loaded with GHK-Cu were deposited on titanium; copper release depended on surface pH, and the coating reduced bacterial adhesion while remaining cytocompatible [3]. None of these three studies reports bone formation in an animal defect model.

Soft tissue, vessels and nerve

On electrospun poly(ε-caprolactone) scaffolds coated with collagen and chitosan, a GHK-Cu surface coating increased cell proliferation, and the GHK-Cu-coated sample showed the strongest antibacterial activity of the coatings compared [10]. In a macroporous cryogel model, combining RGD with GHK, and then with copper(II), sharply increased endothelial cell proliferation and the production of angiogenesis-related cytokines and growth factors [11]. The same group later activated a channelled cryogel with IKVAV, RGD, GHK and LRE peptides and reported scaffold integration and host cell infiltration after acute implantation in a minipig spinal cord transection pilot study [12].

A fascia regeneration study used GHK-Cu as a sustained copper source together with lipid nanoparticles delivering mRNA for the copper chaperone ATOX1. Lysyl oxidase activity rose to 1.78 times control in vitro, and the construct improved collagen alignment and new vessel formation in a rabbit fascia defect [4]. A hydroxyapatite microsphere gel loaded with GHK-Cu released the peptide over 7 days and reduced inflammatory factors and reactive oxygen species in LPS models [13].

Reading this literature critically

  • Construct, not peptide. In most studies GHK or GHK-Cu is one ingredient of a scaffold, conjugate or coating [6,8,4,12], so effects belong to the whole construct.
  • Copper or no copper. Some studies describe GHK without copper [2,7] and others the copper complex [8,3]. In the conjugate work, copper itself is proposed as the active signal [9], which our coordination-chemistry article discusses.
  • Mostly in vitro. Animal data are limited to a few defect or implantation models [6,4,12], and the spinal cord study was a pilot focused on integration, not functional recovery [12].
  • Not always positive. The early osteoblast study found reduced, not increased, markers of osteoblast phenotype with GHK-Cu coating [1].

What remains open

  • Whether grafted, released and free GHK-Cu behave alike, and how much intact peptide remains in a scaffold over time.
  • Whether in vitro osteogenic and angiogenic signals translate into bone or nerve repair in controlled animal studies with peptide-free control constructs.

GHK-Cu 50mg at PurixLab

GHK-Cu 50mg: a labelled lyophilized research vial with 50mg per vial, C$49 per vial (CAD, before tax), supplied for laboratory research only. It is not a cosmetic; our separate Copper Facial Mask is the finished cosmetic product. Batch documentation is available on request. Product page: purixlab.com/product/ghk-cu-50mg/.

PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.

In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.

Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Current offers and any pack pricing are shown on the product page and in your cart; offers do not stack.

For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.

View GHK-Cu 50mg

Questions or batch documentation requests: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ

References

  1. Godet D, Marie PJ. Effects of the tripeptide glycyl-L-histidyl-L-lysine copper complex on osteoblastic cell spreading, attachment and phenotype. Cell Mol Biol (Noisy-le-grand). 1995;41(8):1081-91. PubMed 8747089
  2. Jose S, Hughbanks ML, Binder BY, et al. Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels. Acta Biomater. 2014;10(5):1955-64. PubMed 24468583 · PMC3976757 · doi:10.1016/j.actbio.2014.01.020
  3. Ning C, Jiajia J, Meng L, et al. Electrophoretic deposition of GHK-Cu loaded MSN-chitosan coatings with pH-responsive release of copper and its bioactivity. Mater Sci Eng C Mater Biol Appl. 2019;104:109746. PubMed 31500015 · doi:10.1016/j.msec.2019.109746
  4. Wang R, Xu Y, Saiding Q, et al. Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins' activity for fascia regeneration. J Control Release. 2026;390:114521. PubMed 41371501 · doi:10.1016/j.jconrel.2025.114521
  5. Pesáková V, Novotná J, Adam M. Effect of the tripeptide glycyl-L-histidyl-L-lysine on the proliferation and synthetic activity of chick embryo chondrocytes. Biomaterials. 1995;16(12):911-5. PubMed 8562779 · doi:10.1016/0142-9612(95)93115-t
  6. Pohunková H, Stehlík J, Váchal J, et al. Morphological features of bone healing under the effect of collagen-graft-glycosaminoglycan copolymer supplemented with the tripeptide Gly-His-Lys. Biomaterials. 1996;17(16):1567-74. PubMed 8842360 · doi:10.1016/0142-9612(95)00310-x
  7. Klontzas ME, Reakasame S, Silva R, et al. Oxidized alginate hydrogels with the GHK peptide enhance cord blood mesenchymal stem cell osteogenesis: A paradigm for metabolomics-based evaluation of biomaterial design. Acta Biomater. 2019;88:224-240. PubMed 30772514 · doi:10.1016/j.actbio.2019.02.017
  8. Su J, Zhang Y, Cao Y, et al. Hierarchical regulation and mechanism of "open-hollow-fibrous network" structures: Osteogenic-angiogenic coupling responses of poly(γ-benzyl-L-glutamate) microspheres. Biomater Adv. 2026;188:215017. PubMed 42320090 · doi:10.1016/j.bioadv.2026.215017
  9. Greco V, Lanza V, Tomasello B, et al. Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. Bioconjug Chem. 2025;36(4):662-675. PubMed 40123442 · doi:10.1021/acs.bioconjchem.4c00545
  10. Molavi AM, Sadeghi-Avalshahr A, Nokhasteh S, et al. Enhanced biological properties of collagen/chitosan-coated poly(ε-caprolactone) scaffold by surface modification with GHK-Cu peptide and 58S bioglass. Prog Biomater. 2020;9(1-2):25-34. PubMed 32248401 · PMC7289912 · doi:10.1007/s40204-020-00129-0
  11. Zoughaib M, Luong D, Garifullin R, et al. Enhanced angiogenic effects of RGD, GHK peptides and copper (II) compositions in synthetic cryogel ECM model. Mater Sci Eng C Mater Biol Appl. 2021;120:111660. PubMed 33545827 · doi:10.1016/j.msec.2020.111660
  12. Zoughaib M, Lavrov IA, Dayob K, et al. Peptide-Activated ECM-Mimicking Channeled OPF Cryogel Scaffold for Spinal Cord Lesion Bridging: Development and Pilot Study in Minipigs. Macromol Biosci. 2026;26(10):e70275. PubMed 42908029 · doi:10.1002/mabi.70275
  13. Hu D, Zhang X, Gong S, et al. An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant. Colloids Surf B Biointerfaces. 2025;256(Pt 1):114982. PubMed 40716276 · doi:10.1016/j.colsurfb.2025.114982

Leave a Comment

Your email address will not be published. Required fields are marked *